Rare diseases
Investigational molecules
Locations
Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer
ItalyStudy on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin
ItalyStudy of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
ItalyStudy on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
ItalyStudy on MK-6194 for Adults with Systemic Lupus Erythematosus
ItalyStudy of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
ItalyStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
ItalyStudy on the Effects and Safety of Crovalimab for Adults and Adolescents with Atypical Hemolytic Uremic Syndrome (aHUS)
ItalyStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
ItalyStudy on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
ItalyStudy on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis
ItalyStudy of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
